Listen

Description

Join Ross Lagoy  and Marshall discussing CRISPR/Cas9 genome editing, developing critical platform technologies that accelerate drug discovery and how to connect the bench to automation. Ross is a Senior Scientist at Intellia Therapeutics working to establishing new technologies and analysis pipelines to help identify potential cures for patients living with genetic disease.

Upcoming Events:

View the full events calendar